Huntington National Bank’s AngioDynamics ANGO Stock Holding History

Huntington National Bank’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-460	Closed	-$5.14K	–	4116
2025 Q3	$5.14K	Buy	+460	New	+$4.44K	﹤0.01%	2005

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Kotler Kevin $427M AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

WCM

Weber Capital Management San Francisco, California $100M AUM

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Huntington National Bank's ANGO Position: Q4 2025 in Review

Huntington National Bank sold out of AngioDynamics (ANGO) in Q4 2025, closing a stake of 460 shares — an estimated $5.14K sold.

Huntington National Bank first reported a position in ANGO in Q3 2025 and held it in 1 quarter. The position peaked at $5.14K in Q3 2025. 167 funds tracked by Wall St. Rank hold ANGO as of Q4 2025.

Huntington National Bank reported no remaining AngioDynamics position as of Q4 2025 after selling out during the quarter.
Huntington National Bank sold 460 AngioDynamics shares in Q4 2025, an estimated $5.14K.
Huntington National Bank first reported a position in AngioDynamics in Q3 2025 and held it in 1 quarter.
Huntington National Bank's AngioDynamics position peaked at $5.14K in Q3 2025.
167 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2025.

Based on Huntington National Bank's 13F filing for Q4 2025, filed 9 Feb 2026.